
Idaho Medical Marijuana Campaign Surpasses 100,000 Signatures Ahead of Ballot Deadline
Idaho's medical marijuana campaign has collected over 100,000 signatures as it races to qualify a legalization measure for the November ballot before the April 30 deadline
Key Points
- 1Supporters have gathered more than 100,000 signatures for the Idaho medical cannabis ballot initiative
- 2The Natural Medicine Alliance of Idaho is leading the campaign with backing from local advocates and funding from Double Springs Ranch
- 3The initiative must collect signatures from at least 6 percent of voters statewide and in 18 of 35 legislative districts by April 30
- 4The Idaho Legislature has proposed a constitutional amendment to restrict marijuana legalization authority to lawmakers and opposes the medical cannabis initiative
A campaign to legalize medical cannabis in Idaho has gathered more than 100,000 signatures, as supporters make a final push to meet the April 30 deadline for the November ballot. The Natural Medicine Alliance of Idaho is leading the initiative, aiming to provide legal access to medical cannabis for residents with debilitating conditions such as cancer, PTSD, epilepsy, and Alzheimer’s disease. Idaho remains one of the few states in the region without any form of legalized cannabis, while all bordering states except Wyoming have either medical or recreational programs in place
Advocates emphasize the need for medical cannabis as an alternative to opioids, citing personal stories of hardship and cross-border travel to obtain relief. Amanda Watson, a spokesperson for the initiative, highlighted the desperation of Idahoans seeking dignity in their care: “We’ve had hundreds of people email us about how they’re suffering with PTSD or they’re suffering with epilepsy and they’re driving across the border and illegally buying gummies because they would like some dignity in their care, in their state, but they can’t get it.” The proposed framework includes strict regulation and limited access, focusing on medical use rather than recreational
The campaign is backed by Rob Cronin, a Sun Valley entrepreneur and cancer survivor, whose experiences with opioid side effects inspired his advocacy. Cronin recounted his ordeal with opioid medications, stating, “I can tell you firsthand that I would have chosen a cannabis alternative to opioids all day long, because the opioid puts you on that funky roller coaster of, ‘Oh, I feel better. Oh, I’m depressed, and my life sucks. Oww, now I’m in pain. another opioid. Oh, I’m depressed again and my life sucks.’” Much of the initiative’s funding comes from Double Springs Ranch, previously owned by fellow advocate Dr. Dori Tunney, whose battle with cancer and positive experience with medical cannabis in California helped shape the campaign
To secure a spot on the November ballot, organizers must gather signatures from 6 percent of registered voters statewide—at least 70,725 valid signatures—and meet the same threshold in at least 18 of Idaho’s 35 legislative districts. The Natural Medicine Alliance has deployed paid signature gatherers, offering $25 per hour plus incentives, to reach rural areas and ensure district-level compliance. As of last week, over 100,000 raw signatures had been collected, but only a portion have been validated by the Idaho Secretary of State’s office so far, underscoring the urgency of the final days
The Idaho Legislature, led by Republicans, opposes the measure and has put forward a competing constitutional amendment, House Joint Resolution 4, which would restrict marijuana legalization authority to lawmakers only. Legislators argue that the medical cannabis act lacks sufficient safeguards and warn that its qualifying conditions are so broad that "almost anyone could qualify." The state has recently stiffened penalties for marijuana possession and adopted resolutions urging voters to reject the initiative, citing concerns about increased costs and regulatory challenges for the Department of Health and Welfare
From the OG Lab editorial perspective, Idaho’s campaign is a critical test of direct democracy and the shifting landscape of cannabis reform in conservative states. The outcome will be closely watched by advocates nationwide as a barometer for grassroots mobilization and legislative resistance. Should the measure qualify for the ballot, Idaho could become a pivotal battleground in the ongoing debate over medical cannabis access in the U.S


